Study to Assess the Safety and Tolerability of Single Doses of REGN1500
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
Phase 1, first-in-human, randomized, ascending single-dose, placebo-controlled, double-blind
study of the safety, tolerability, and bioeffect of REGN1500